glp-1 receptor agonists for weight loss Study finds target fat over muscle GLP-1 receptor agonists – How

By improving metabolic regulation, moderating nutrient signaling, and reducing chronic inflammatory burden, these therapies may help alleviate physiological stress that contributes to age-related disease and functional decline

In addition to dual GLP-1R/GIPR-targeted drugs, the development of GLP-1R/GCGR dual-target drugs and GLP-1R/GIPR/GCGR triple-target drugs is a focus of ongoing multi-target GLP-1 drug development

In addition to treating obesity and Type 2 diabetes, GLP-1s have also shown promise with substance use disorders (SUD)

Gastroenterol Hepatol (N Y)

Studies have shown that certain bacterial genera such as Bacteroides, Akkermansia, Faecalibacterium, Roseburia, and Bifidobacterium are negatively associated with T2DM, while others like Blautia, Fusobacterium, and Ruminococcus are positively associated with T2DM [156]

The patient information documents complement the recommendations in the guidance document.